A simplified scoring system for predicting treatment response in limited-stage small-cell lung cancer (EAST score)
EAST score effectively predicts recurrence risk in LS-SCLC, demonstrating the necessity for developing new treatment strategies for high-risk patients.
Authors
- Hiroki Izumi (ORCID: https://orcid.org/0000-0002-9566-4859)
- Kiyotaka Yoh
- Yuji Shibata (ORCID: https://orcid.org/0000-0002-3193-4207)
- Takehiro Izumo (ORCID: https://orcid.org/0000-0002-9052-0063)
- Tetsuya Sakai (ORCID: https://orcid.org/0000-0001-5884-2735)
- Kōichi Goto (ORCID: https://orcid.org/0000-0002-3023-2510)
- Masaki Nakamura (ORCID: https://orcid.org/0000-0002-4431-8892)
- Kaname Nosaki (ORCID: https://orcid.org/0000-0002-1800-9455)
- Yu Ito (ORCID: https://orcid.org/0000-0002-9047-1919)
- Hidehiro Hojo
- Yoshitaka Zenke (ORCID: https://orcid.org/0000-0002-7641-9065)
- S. Umemura
- Shingo Matsumoto (ORCID: https://orcid.org/0000-0001-9627-5401)
Institutions
- Japanese Red Cross Medical Center (JP)
- National Cancer Center Hospital East (JP)
Publication Details
- Journal
- Future Oncology
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1080/14796694.2024.2444858
- Citations
- 2
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57